We have also recently demonstrated the importance of LAG-3 in cHL by showing that gene expression of LAG-3 was threefold higher in cHL compared to diffuse large B-cell lymphoma (DLBCL) cases [75]. The gene discussed is LAG3; the disease is diffuse large B-cell lymphoma.